What is the most likely diagnosis for a patient from Nigeria presenting with high fever (103 °F), severe frontal headache, vomiting, severe thrombocytopenia, and extremely elevated C‑reactive protein?

Severe Malaria (Plasmodium falciparum)

This patient from Nigeria presenting with high fever (103°F), severe frontal headache, vomiting, severe thrombocytopenia (38,000/μL), markedly elevated CRP (547 mg/L), and positive malaria smear most likely has severe Plasmodium falciparum malaria requiring immediate intensive care admission and intravenous artesunate.

Diagnostic Reasoning

The clinical presentation strongly indicates severe malaria based on the following key features 1:

• Geographic origin: Nigeria is a malaria-endemic region where P. falciparum predominates
• Positive malaria smear: Confirms parasitemia (though species and percentage need clarification)
• Severe thrombocytopenia: Platelet count of 38,000/μL meets WHO criteria for severe malaria (similar to Case 3 with 27,000/μL) 1
• Markedly elevated CRP: 547 mg/L indicates severe systemic inflammation
• Classic symptoms: High fever, severe frontal headache, and vomiting are characteristic malaria symptoms 1

Critical Severity Assessment

Thrombocytopenia (<150,000/μL) is the most frequent laboratory finding in malaria, occurring in 70-79% of cases regardless of species 1. However, severe thrombocytopenia (<50,000/μL) combined with the clinical presentation suggests this is not uncomplicated malaria.

The guideline Case 3 1 demonstrates a nearly identical presentation: thrombocytopenia (27,000/μL), high fever, and systemic symptoms with P. falciparum requiring ICU admission and IV artesunate.

Immediate Management Algorithm

1. Confirm Severity Criteria

Immediately assess for WHO severe malaria criteria:

• Severe thrombocytopenia (✓ present: 38,000/μL)
• Impaired consciousness/seizures
• Respiratory distress
• Circulatory collapse
• Acute kidney injury (check creatinine)
• Hypoglycemia
• Severe anemia
• Hyperbilirubinemia
• Acidosis (check lactate, bicarbonate)
• Hyperparasitemia (determine parasitemia percentage urgently)

2. Urgent Laboratory Work

• Parasitemia quantification (critical for severity assessment)
• Complete blood count with hemoglobin
• Renal function (creatinine, urea)
• Liver function (bilirubin, ALT)
• Blood glucose
• Blood gas analysis (lactate, bicarbonate)
• Blood cultures (to exclude bacterial co-infection)

3. Treatment Initiation

If ANY severity criteria present (thrombocytopenia <50,000/μL qualifies):

• Immediate ICU admission 1
• Intravenous artesunate as first-line therapy 1
• Supportive care with fluid management
• Monitor for complications

Monitoring protocol 1:

• Check parasitemia every 12 hours until <1%, then every 24 hours until negative
• Daily complete blood count, renal, hepatic, and metabolic panels
• Transition to oral artemisinin-based combination therapy (ACT) after 3 doses of artesunate when parasitemia <1% and patient can tolerate oral intake
• Monitor for delayed hemolysis on days 7,14,21, and 28 1

Critical Pitfalls to Avoid

1. Delayed diagnosis kills: P. falciparum malaria is frequently overlooked initially in non-endemic settings, leading to preventable deaths 1. The positive smear here prevents this, but severity must not be underestimated.

2. Don't wait for all severity criteria: Severe thrombocytopenia alone warrants aggressive management. The guideline explicitly states patients meeting even one severity criterion require ICU care 1.

3. Screen all severe thrombocytopenia: Any patient with platelets <100,000/μL from endemic areas should be screened for malaria 1.

4. Don't use oral therapy initially: Severe malaria requires IV artesunate, not oral ACT 1.

Alternative Considerations (Less Likely)

While Lassa fever is endemic in Nigeria 2 and can present with fever, headache, and thrombocytopenia, the positive malaria smear makes this the primary diagnosis. However, if the patient fails to respond to antimalarial therapy or deteriorates despite treatment, consider:

• Bacterial co-infection (sepsis can cause similar CRP elevation)
• Lassa fever co-infection (though less common, can occur) 2
• Dengue fever (if travel history includes urban areas)

The extremely elevated CRP (547 mg/L) is consistent with severe malaria's inflammatory response, though bacterial sepsis should remain on the differential if blood cultures are pending.

Bottom line: Treat as severe P. falciparum malaria with IV artesunate in ICU setting immediately 1.